258 related articles for article (PubMed ID: 15645675)
21. Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures.
Zakrzewska K; Cortivo R; Tonello C; Panfilo S; Abatangelo G; Giuggioli D; Ferri C; Corcioli F; Azzi A
Virus Res; 2005 Dec; 114(1-2):1-5. PubMed ID: 15990190
[TBL] [Abstract][Full Text] [Related]
22. Molecular biology and pathogenicity of human and animal parvoviruses.
Siegl G
Behring Inst Mitt; 1990 Aug; (85):6-13. PubMed ID: 2171487
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a new LightCycler reverse transcription-polymerase chain reaction infectivity assay for detection of human parvovirus B19 in dry-heat inactivation studies.
Prikhod'ko GG; Vasilyeva I; Reyes H; Wong S; Brown KE; Jameson T; Busby TF
Transfusion; 2005 Jun; 45(6):1011-9. PubMed ID: 15935001
[TBL] [Abstract][Full Text] [Related]
24. Functional analysis and quantitative determination of the expression profile of human parvovirus B19.
Bonvicini F; Filippone C; Manaresi E; Zerbini M; Musiani M; Gallinella G
Virology; 2008 Nov; 381(2):168-77. PubMed ID: 18838151
[TBL] [Abstract][Full Text] [Related]
25. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
Manning A; Willey SJ; Bell JE; Simmonds P
J Infect Dis; 2007 May; 195(9):1345-52. PubMed ID: 17397006
[TBL] [Abstract][Full Text] [Related]
26. Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.
Sharp CP; LeBreton M; Kantola K; Nana A; Diffo Jle D; Djoko CF; Tamoufe U; Kiyang JA; Babila TG; Ngole EM; Pybus OG; Delwart E; Delaporte E; Peeters M; Soderlund-Venermo M; Hedman K; Wolfe ND; Simmonds P
J Virol; 2010 Oct; 84(19):10289-96. PubMed ID: 20668071
[TBL] [Abstract][Full Text] [Related]
27. Human parvovirus B19 in patients with aplastic anemia.
Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
[TBL] [Abstract][Full Text] [Related]
28. Parvovirus B19 infection after plasma exchange for myasthenia gravis.
Bianchi M; Rago I; Zini G; D'Onofrio G; Leone G
Lab Hematol; 2007; 13(1):34-8. PubMed ID: 17353182
[TBL] [Abstract][Full Text] [Related]
29. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients.
Ki CS; Kim IS; Kim JW; Lee NY; Kim SH; Lee KW; Kim SJ; Joh JW; Huh WS; Oh HY
Clin Transplant; 2005 Dec; 19(6):751-5. PubMed ID: 16313320
[TBL] [Abstract][Full Text] [Related]
30. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes.
Parsyan A; Szmaragd C; Allain JP; Candotti D
J Gen Virol; 2007 Feb; 88(Pt 2):428-431. PubMed ID: 17251559
[TBL] [Abstract][Full Text] [Related]
31. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
[TBL] [Abstract][Full Text] [Related]
32. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection.
Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Duechting A; Kaiser H; Torresi J; Kandolf R; Bock CT
J Hepatol; 2006 Sep; 45(3):361-9. PubMed ID: 16684578
[TBL] [Abstract][Full Text] [Related]
33. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
[TBL] [Abstract][Full Text] [Related]
35. [Human parvovirus B19].
Ishii KK; Sasaki T
Nihon Rinsho; 2003 Mar; 61 Suppl 3():608-14. PubMed ID: 12718036
[No Abstract] [Full Text] [Related]
36. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
[TBL] [Abstract][Full Text] [Related]
37. High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow.
Watanabe K; Otabe K; Shimizu N; Komori K; Mizuno M; Katano H; Koga H; Sekiya I
Stem Cell Res Ther; 2018 Mar; 9(1):80. PubMed ID: 29587847
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of human parvovirus B19 infection.
Ramirez MM; Mastrobattista JM
Clin Perinatol; 2005 Sep; 32(3):697-704. PubMed ID: 16085027
[TBL] [Abstract][Full Text] [Related]
39. Sensitive and rapid diagnosis of human parvovirus B19 infection by loop-mediated isothermal amplification.
Yamada Y; Itoh M; Yoshida M
Br J Dermatol; 2006 Jul; 155(1):50-5. PubMed ID: 16792751
[TBL] [Abstract][Full Text] [Related]
40. Different patterns of restriction to B19 parvovirus replication in human blast cell lines.
Gallinella G; Manaresi E; Zuffi E; Venturoli S; Bonsi L; Bagnara GP; Musiani M; Zerbini M
Virology; 2000 Dec; 278(2):361-7. PubMed ID: 11118359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
